Trials / Recruiting
RecruitingNCT02304913
Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy
Hypoglossal Acupuncture for Dysgeusia in Gynecologic Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- Universität Duisburg-Essen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.
Detailed description
Taste disorders are frequent side effects in patients undergoing chemotherapy (CTX). Dysguesia has prevalence rates of 16% to 1000% during CTX with sometimes also persistent courses. Impact of dysguesia on appetite, body weight as well as health-related quality of life was shown. Until now, evidence for adequate treatment options is limited to specific diary recommendations. Acupuncture in the treatment of side effects of chemotherapy was investigated for nausea and xerostomia, but not for dysguesia. Therefore, this randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hypoglossal acupuncture | |
| OTHER | Sham acupuncture | |
| BEHAVIORAL | Dietary recommendations |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2014-12-02
- Last updated
- 2026-04-14
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02304913. Inclusion in this directory is not an endorsement.